CheckMyRecalls

Nubratori, Inc recalls Dexonto 0.4% (dexamethasone sodium phosphate)…

Nubratori, Inc recalls Dexonto 0.4% (dexamethasone sodium phosphate) solution 20 mg/5 mL (…

Published
7 May 2025
Units affected
20 boxes
Agency
FDA
Country
United States

The hazard

Labeling: Incorrect or Missing Lot and/or Expiration date: Individual vials of Dexonto 0.4%, are labeled correctly with the BUD of 12/25/2024, however, the outer box on some of the Dexonto 0.4% are labeled incorrectly with a BUD of 12/25/2025.

Classification: Class II — this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.

What to do

Do not stop a prescribed medicine without talking to your doctor or pharmacist first. Ask them about a replacement, and return the recalled product to the pharmacy.

  • Check the lot number on the box or bottle.
  • Talk to your pharmacist or doctor before stopping any prescribed medicine.
  • Return the product to the pharmacy for safe disposal.
Read the official FDA notice

Product details

Dexonto 0.4% (dexamethasone sodium phosphate) solution 20 mg/5 mL (4 mg/mL), Rx Only, 12 - 5 mL Single Dose Units per box, Preservative Free, For Iontophoresis Use Only, Non-Sterile Product, Not for Injection, NUBRATORI RX, 381 Van Ness Ave# 1507, CA 90501, NDC 71300-6564-1 (box), 71300-6564-3 (vial).

Brand / company
Nubratori, Inc
Codes / lots
Lot #: C04292401X1, BUD: 12/25/2025 (box).
Distribution
PA and CA.
Recall status
Ongoing

Source: U.S. Food and Drug Administration, published 7 May 2025. CheckMyRecalls reproduces the official notice in summary; always confirm the details with the original notice.